Div Payers personal page - To The Moon

Div Payers

No personal profile

3Follow

0Followers

0Topic

0Badge

2022-01-13

wow

Quest Diagnostics says COVID-19 testing volumes surge as Omicron spreads

2022-01-13

like

S.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills

2022-01-13

like

ARK's Wood turns focus to deflation, 'stay connected' stocks

2022-01-13

interesting

Bed Bath & Beyond rose nearly 5% premarket as its CFO executed a purchase for 15,000 shares

2022-01-13

amazing

Didi in talks for a second-quarter IPO in Hong Kong on its way to delisting from New York, sources say

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4103261011790040","uuid":"4103261011790040","gmtCreate":1641099170152,"gmtModify":1682753389382,"name":"Div Payers","pinyin":"divpayersdivpayers","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":3,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.20","exceedPercentage":"93.06%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.01","exceedPercentage":"60.46%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9002675331,"gmtCreate":1642007356996,"gmtModify":1676533671182,"author":{"id":"4103261011790040","authorId":"4103261011790040","name":"Div Payers","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4103261011790040","authorIdStr":"4103261011790040"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002675331","repostId":"2202394577","repostType":4,"repost":{"id":"2202394577","pubTimestamp":1641970114,"share":"https://ttm.financial/m/news/2202394577?lang=&edition=fundamental","pubTime":"2022-01-12 14:48","market":"us","language":"en","title":"S.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills","url":"https://stock-news.laohu8.com/highlight/detail?id=2202394577","media":"Reuters","summary":"(Reuters) -South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge","content":"<html><head></head><body><p>(Reuters) -South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorising the use of Novavax Inc&#39;s vaccine on Wednesday and preparing to distribute the first of Pfizer&#39;s antiviral pills.</p><p>At least 21,000 of Pfizer&#39;s antiviral pills, called Paxlovid, will arrive in South Korea on Thursday, with another 10,000 more expected to arrive by the end of the month, the health ministry said.</p><p>The pills, which were authorised for emergency use in December, will begin being used in treatments for more than 1,000 people per day starting on Friday, the ministry added</p><p>&#34;By priority, oral treatment is planned to begin first for patients aged 65 or older, or patients with reduced immunity at home and residential treatment centres,&#34; a ministry spokesperson told a briefing.</p><p>Paxlovid was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer has said.</p><p>South Korea&#39;s food and drug safety ministry, meanwhile, announced it had authorised the Novavax  vaccine, which joins the ranks of previously authorised vaccines made by AstraZeneca Inc, Moderna Inc, Pfizer, and Johnson &amp; Johnson&#39;s Janssen.</p><p>South Korean vaccine developer SK Bioscience Co Ltd said it will produce the Novavax   vaccine.</p><p>The two-dose, protein-based vaccine has secured authorisations from European Union regulators and the World Health Organization.</p><p>It has been authorised in India, Indonesia and the Philippines, where Novavax&#39;s partner, Serum Institute of India, will supply it.</p><p>Novavax is awaiting approval in Japan, where its vaccine would be manufactured and distributed by Takeda Pharmaceutical.</p><p>At least 84.2% of the country&#39;s 52 million population have been fully vaccinated, while 42.5%, have received booster shots, according to health officials.</p><p>South Korea added 4,388 new COVID-19 cases as of midnight Tuesday, for a total of 674,868 cases and 6,166 deaths since the pandemic began, the Korea Disease Control and Prevention Agency (KDCA) reported.</p><p>That number has dipped from all-time highs of nearly 8,000 daily cases in mid-December, when authorities re-imposed strict social distancing measures to try to stem the tide.</p><p>Omicron only accounts for a fraction of South Korea&#39;s cases so far, but that percentage has risen to more than 12.5% from 4% at the end of December, health officials said on Wednesday.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-12 14:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19450276><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) -South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorising the use of Novavax Inc's vaccine on Wednesday and ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19450276\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","BK4568":"美国抗疫概念","BK4534":"瑞士信贷持仓"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19450276","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2202394577","content_text":"(Reuters) -South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorising the use of Novavax Inc's vaccine on Wednesday and preparing to distribute the first of Pfizer's antiviral pills.At least 21,000 of Pfizer's antiviral pills, called Paxlovid, will arrive in South Korea on Thursday, with another 10,000 more expected to arrive by the end of the month, the health ministry said.The pills, which were authorised for emergency use in December, will begin being used in treatments for more than 1,000 people per day starting on Friday, the ministry added\"By priority, oral treatment is planned to begin first for patients aged 65 or older, or patients with reduced immunity at home and residential treatment centres,\" a ministry spokesperson told a briefing.Paxlovid was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer has said.South Korea's food and drug safety ministry, meanwhile, announced it had authorised the Novavax  vaccine, which joins the ranks of previously authorised vaccines made by AstraZeneca Inc, Moderna Inc, Pfizer, and Johnson & Johnson's Janssen.South Korean vaccine developer SK Bioscience Co Ltd said it will produce the Novavax   vaccine.The two-dose, protein-based vaccine has secured authorisations from European Union regulators and the World Health Organization.It has been authorised in India, Indonesia and the Philippines, where Novavax's partner, Serum Institute of India, will supply it.Novavax is awaiting approval in Japan, where its vaccine would be manufactured and distributed by Takeda Pharmaceutical.At least 84.2% of the country's 52 million population have been fully vaccinated, while 42.5%, have received booster shots, according to health officials.South Korea added 4,388 new COVID-19 cases as of midnight Tuesday, for a total of 674,868 cases and 6,166 deaths since the pandemic began, the Korea Disease Control and Prevention Agency (KDCA) reported.That number has dipped from all-time highs of nearly 8,000 daily cases in mid-December, when authorities re-imposed strict social distancing measures to try to stem the tide.Omicron only accounts for a fraction of South Korea's cases so far, but that percentage has risen to more than 12.5% from 4% at the end of December, health officials said on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002672754,"gmtCreate":1642007332321,"gmtModify":1676533671174,"author":{"id":"4103261011790040","authorId":"4103261011790040","name":"Div Payers","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4103261011790040","authorIdStr":"4103261011790040"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002672754","repostId":"2202784029","repostType":4,"repost":{"id":"2202784029","pubTimestamp":1641975420,"share":"https://ttm.financial/m/news/2202784029?lang=&edition=fundamental","pubTime":"2022-01-12 16:17","market":"us","language":"en","title":"ARK's Wood turns focus to deflation, 'stay connected' stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2202784029","media":"StreetInsider","summary":"NEW YORK (Reuters) -     Star stock picker Cathie Wood of ARK Invest doubled down on her bet that de","content":"<html><head></head><body><p>NEW YORK (Reuters) -     Star stock picker Cathie Wood of ARK Invest doubled down on her bet that deflation, rather than inflation, will be the largest factor in the U.S. economy in the year ahead in a webinar on Tuesday.</p><p>Wood, whose <a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a> was the top-performing U.S. equity fund tracked by Morningstar in 2020 before plummeting to among the worst performers of 2021, pushed back against the idea that companies in her portfolio such as <a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video Communications Inc and Teladoc Health Inc were simply beneficiaries of the economic lockdowns at the start of the coronavirus pandemic.</p><p>&#34;They are not stay-at-home stocks, they are stay connected stocks,&#34; she said.</p><p>Zoom, for instance, should &#34;have stunning growth rates ahead&#34; while Teladoc will become the &#34;backbone&#34; of the U.S. healthcare system, she said.</p><p>Inflation, meanwhile, will fall this year as supply chain bottlenecks ease and companies no longer feel the need to put in double or triple orders for goods, Wood predicted. At the same time, technology will continue to push down prices of goods and services, she said.</p><p>&#34;Companies are learning how powerful technology can be on holding the line on costs,&#34; Wood said.</p><p>The ARK Innovation ETF is down 7.6% for the year to date as rising interest rates have weighed down on the sort of high-growth, high-valuation companIEs in its portfolio.</p><p>The fund was up 3.2% in afternoon trading Monday.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ARK's Wood turns focus to deflation, 'stay connected' stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nARK's Wood turns focus to deflation, 'stay connected' stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-12 16:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19448326><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (Reuters) -     Star stock picker Cathie Wood of ARK Invest doubled down on her bet that deflation, rather than inflation, will be the largest factor in the U.S. economy in the year ahead in ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19448326\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKK":"ARK Innovation ETF","BK4544":"ARK ETF合集"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19448326","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2202784029","content_text":"NEW YORK (Reuters) -     Star stock picker Cathie Wood of ARK Invest doubled down on her bet that deflation, rather than inflation, will be the largest factor in the U.S. economy in the year ahead in a webinar on Tuesday.Wood, whose ARK Innovation ETF was the top-performing U.S. equity fund tracked by Morningstar in 2020 before plummeting to among the worst performers of 2021, pushed back against the idea that companies in her portfolio such as Zoom Video Communications Inc and Teladoc Health Inc were simply beneficiaries of the economic lockdowns at the start of the coronavirus pandemic.\"They are not stay-at-home stocks, they are stay connected stocks,\" she said.Zoom, for instance, should \"have stunning growth rates ahead\" while Teladoc will become the \"backbone\" of the U.S. healthcare system, she said.Inflation, meanwhile, will fall this year as supply chain bottlenecks ease and companies no longer feel the need to put in double or triple orders for goods, Wood predicted. At the same time, technology will continue to push down prices of goods and services, she said.\"Companies are learning how powerful technology can be on holding the line on costs,\" Wood said.The ARK Innovation ETF is down 7.6% for the year to date as rising interest rates have weighed down on the sort of high-growth, high-valuation companIEs in its portfolio.The fund was up 3.2% in afternoon trading Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":182,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002672441,"gmtCreate":1642007313209,"gmtModify":1676533671190,"author":{"id":"4103261011790040","authorId":"4103261011790040","name":"Div Payers","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4103261011790040","authorIdStr":"4103261011790040"},"themes":[],"htmlText":"interesting","listText":"interesting","text":"interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002672441","repostId":"1108839614","repostType":4,"isVote":1,"tweetType":1,"viewCount":333,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002672566,"gmtCreate":1642007297933,"gmtModify":1676533671190,"author":{"id":"4103261011790040","authorId":"4103261011790040","name":"Div Payers","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4103261011790040","authorIdStr":"4103261011790040"},"themes":[],"htmlText":"amazing","listText":"amazing","text":"amazing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002672566","repostId":"1166686175","repostType":4,"repost":{"id":"1166686175","pubTimestamp":1641983722,"share":"https://ttm.financial/m/news/1166686175?lang=&edition=fundamental","pubTime":"2022-01-12 18:35","market":"us","language":"en","title":"Didi in talks for a second-quarter IPO in Hong Kong on its way to delisting from New York, sources say","url":"https://stock-news.laohu8.com/highlight/detail?id=1166686175","media":"South China Morning Post","summary":"Didi Global is in talks to launch its initial public offering (IPO)in Hong Kong in the second quarte","content":"<html><head></head><body><p>Didi Global is in talks to launch its initial public offering (IPO)in Hong Kong in the second quarter, as China&#39;s dominant ride-hailing company prepares to exit the New York Stock Exchange (NYSE), according to two sources familiar with the matter.</p><p>Didi&#39;s bankers have had preliminary discussions with the Hong Kong Exchanges and Clearing Limited(HKEX) before submitting the A1 form to officially apply to list on the exchange, according to the sources, requesting anonymity for discussing a matter before its announcement.</p><p>Depending on market conditions, the Beijing-based company may list in Hong Kong in the second quarter, the sources said, adding that the financial terms of the proposed listing are still being worked on. HKEX&#39;s spokesman declined to comment on individual cases.</p></body></html>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Didi in talks for a second-quarter IPO in Hong Kong on its way to delisting from New York, sources say</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDidi in talks for a second-quarter IPO in Hong Kong on its way to delisting from New York, sources say\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-12 18:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/didi-talks-second-quarter-ipo-093000904.html><strong>South China Morning Post</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Didi Global is in talks to launch its initial public offering (IPO)in Hong Kong in the second quarter, as China's dominant ride-hailing company prepares to exit the New York Stock Exchange (NYSE), ...</p>\n\n<a href=\"https://finance.yahoo.com/news/didi-talks-second-quarter-ipo-093000904.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIDI":"滴滴(已退市)"},"source_url":"https://finance.yahoo.com/news/didi-talks-second-quarter-ipo-093000904.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166686175","content_text":"Didi Global is in talks to launch its initial public offering (IPO)in Hong Kong in the second quarter, as China's dominant ride-hailing company prepares to exit the New York Stock Exchange (NYSE), according to two sources familiar with the matter.Didi's bankers have had preliminary discussions with the Hong Kong Exchanges and Clearing Limited(HKEX) before submitting the A1 form to officially apply to list on the exchange, according to the sources, requesting anonymity for discussing a matter before its announcement.Depending on market conditions, the Beijing-based company may list in Hong Kong in the second quarter, the sources said, adding that the financial terms of the proposed listing are still being worked on. HKEX's spokesman declined to comment on individual cases.","news_type":1},"isVote":1,"tweetType":1,"viewCount":295,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002672604,"gmtCreate":1642007195553,"gmtModify":1676533671182,"author":{"id":"4103261011790040","authorId":"4103261011790040","name":"Div Payers","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4103261011790040","authorIdStr":"4103261011790040"},"themes":[],"htmlText":"wow","listText":"wow","text":"wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002672604","repostId":"1191890536","repostType":4,"repost":{"id":"1191890536","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1642000237,"share":"https://ttm.financial/m/news/1191890536?lang=&edition=fundamental","pubTime":"2022-01-12 23:10","market":"us","language":"en","title":"Quest Diagnostics says COVID-19 testing volumes surge as Omicron spreads","url":"https://stock-news.laohu8.com/highlight/detail?id=1191890536","media":"Reuters","summary":"Jan 12 (Reuters) - Quest Diagnostics said on Wednesday it was performing more than 100,000 COVID-19 ","content":"<html><head></head><body><p>Jan 12 (Reuters) - Quest Diagnostics said on Wednesday it was performing more than 100,000 COVID-19 tests a day, as the Omicron coronavirus variant drives a surge in testing demand in the United States.</p><p>&#34;We saw a steep increase in our volumes in the fourth quarter, particularly the last two weeks in December, and it continues into January,&#34; Quest Diagnostics Chief Executive Officer Steve Rusckowski said at the annual J.P. Morgan Health Care conference.</p><p>The company said it performed over 120,000 PCR tests per day in the last couple of weeks of 2021, and over 150,000 tests a day at the beginning of this year.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Quest Diagnostics says COVID-19 testing volumes surge as Omicron spreads</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuest Diagnostics says COVID-19 testing volumes surge as Omicron spreads\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-12 23:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Jan 12 (Reuters) - Quest Diagnostics said on Wednesday it was performing more than 100,000 COVID-19 tests a day, as the Omicron coronavirus variant drives a surge in testing demand in the United States.</p><p>&#34;We saw a steep increase in our volumes in the fourth quarter, particularly the last two weeks in December, and it continues into January,&#34; Quest Diagnostics Chief Executive Officer Steve Rusckowski said at the annual J.P. Morgan Health Care conference.</p><p>The company said it performed over 120,000 PCR tests per day in the last couple of weeks of 2021, and over 150,000 tests a day at the beginning of this year.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DGX":"奎斯特诊疗"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191890536","content_text":"Jan 12 (Reuters) - Quest Diagnostics said on Wednesday it was performing more than 100,000 COVID-19 tests a day, as the Omicron coronavirus variant drives a surge in testing demand in the United States.\"We saw a steep increase in our volumes in the fourth quarter, particularly the last two weeks in December, and it continues into January,\" Quest Diagnostics Chief Executive Officer Steve Rusckowski said at the annual J.P. Morgan Health Care conference.The company said it performed over 120,000 PCR tests per day in the last couple of weeks of 2021, and over 150,000 tests a day at the beginning of this year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9002672604,"gmtCreate":1642007195553,"gmtModify":1676533671182,"author":{"id":"4103261011790040","authorId":"4103261011790040","name":"Div Payers","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4103261011790040","authorIdStr":"4103261011790040"},"themes":[],"htmlText":"wow","listText":"wow","text":"wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002672604","repostId":"1191890536","repostType":4,"repost":{"id":"1191890536","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1642000237,"share":"https://ttm.financial/m/news/1191890536?lang=&edition=fundamental","pubTime":"2022-01-12 23:10","market":"us","language":"en","title":"Quest Diagnostics says COVID-19 testing volumes surge as Omicron spreads","url":"https://stock-news.laohu8.com/highlight/detail?id=1191890536","media":"Reuters","summary":"Jan 12 (Reuters) - Quest Diagnostics said on Wednesday it was performing more than 100,000 COVID-19 ","content":"<html><head></head><body><p>Jan 12 (Reuters) - Quest Diagnostics said on Wednesday it was performing more than 100,000 COVID-19 tests a day, as the Omicron coronavirus variant drives a surge in testing demand in the United States.</p><p>&#34;We saw a steep increase in our volumes in the fourth quarter, particularly the last two weeks in December, and it continues into January,&#34; Quest Diagnostics Chief Executive Officer Steve Rusckowski said at the annual J.P. Morgan Health Care conference.</p><p>The company said it performed over 120,000 PCR tests per day in the last couple of weeks of 2021, and over 150,000 tests a day at the beginning of this year.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Quest Diagnostics says COVID-19 testing volumes surge as Omicron spreads</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuest Diagnostics says COVID-19 testing volumes surge as Omicron spreads\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-12 23:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Jan 12 (Reuters) - Quest Diagnostics said on Wednesday it was performing more than 100,000 COVID-19 tests a day, as the Omicron coronavirus variant drives a surge in testing demand in the United States.</p><p>&#34;We saw a steep increase in our volumes in the fourth quarter, particularly the last two weeks in December, and it continues into January,&#34; Quest Diagnostics Chief Executive Officer Steve Rusckowski said at the annual J.P. Morgan Health Care conference.</p><p>The company said it performed over 120,000 PCR tests per day in the last couple of weeks of 2021, and over 150,000 tests a day at the beginning of this year.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DGX":"奎斯特诊疗"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191890536","content_text":"Jan 12 (Reuters) - Quest Diagnostics said on Wednesday it was performing more than 100,000 COVID-19 tests a day, as the Omicron coronavirus variant drives a surge in testing demand in the United States.\"We saw a steep increase in our volumes in the fourth quarter, particularly the last two weeks in December, and it continues into January,\" Quest Diagnostics Chief Executive Officer Steve Rusckowski said at the annual J.P. Morgan Health Care conference.The company said it performed over 120,000 PCR tests per day in the last couple of weeks of 2021, and over 150,000 tests a day at the beginning of this year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002675331,"gmtCreate":1642007356996,"gmtModify":1676533671182,"author":{"id":"4103261011790040","authorId":"4103261011790040","name":"Div Payers","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4103261011790040","authorIdStr":"4103261011790040"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002675331","repostId":"2202394577","repostType":4,"repost":{"id":"2202394577","pubTimestamp":1641970114,"share":"https://ttm.financial/m/news/2202394577?lang=&edition=fundamental","pubTime":"2022-01-12 14:48","market":"us","language":"en","title":"S.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills","url":"https://stock-news.laohu8.com/highlight/detail?id=2202394577","media":"Reuters","summary":"(Reuters) -South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge","content":"<html><head></head><body><p>(Reuters) -South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorising the use of Novavax Inc&#39;s vaccine on Wednesday and preparing to distribute the first of Pfizer&#39;s antiviral pills.</p><p>At least 21,000 of Pfizer&#39;s antiviral pills, called Paxlovid, will arrive in South Korea on Thursday, with another 10,000 more expected to arrive by the end of the month, the health ministry said.</p><p>The pills, which were authorised for emergency use in December, will begin being used in treatments for more than 1,000 people per day starting on Friday, the ministry added</p><p>&#34;By priority, oral treatment is planned to begin first for patients aged 65 or older, or patients with reduced immunity at home and residential treatment centres,&#34; a ministry spokesperson told a briefing.</p><p>Paxlovid was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer has said.</p><p>South Korea&#39;s food and drug safety ministry, meanwhile, announced it had authorised the Novavax  vaccine, which joins the ranks of previously authorised vaccines made by AstraZeneca Inc, Moderna Inc, Pfizer, and Johnson &amp; Johnson&#39;s Janssen.</p><p>South Korean vaccine developer SK Bioscience Co Ltd said it will produce the Novavax   vaccine.</p><p>The two-dose, protein-based vaccine has secured authorisations from European Union regulators and the World Health Organization.</p><p>It has been authorised in India, Indonesia and the Philippines, where Novavax&#39;s partner, Serum Institute of India, will supply it.</p><p>Novavax is awaiting approval in Japan, where its vaccine would be manufactured and distributed by Takeda Pharmaceutical.</p><p>At least 84.2% of the country&#39;s 52 million population have been fully vaccinated, while 42.5%, have received booster shots, according to health officials.</p><p>South Korea added 4,388 new COVID-19 cases as of midnight Tuesday, for a total of 674,868 cases and 6,166 deaths since the pandemic began, the Korea Disease Control and Prevention Agency (KDCA) reported.</p><p>That number has dipped from all-time highs of nearly 8,000 daily cases in mid-December, when authorities re-imposed strict social distancing measures to try to stem the tide.</p><p>Omicron only accounts for a fraction of South Korea&#39;s cases so far, but that percentage has risen to more than 12.5% from 4% at the end of December, health officials said on Wednesday.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-12 14:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19450276><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) -South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorising the use of Novavax Inc's vaccine on Wednesday and ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19450276\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","BK4568":"美国抗疫概念","BK4534":"瑞士信贷持仓"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19450276","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2202394577","content_text":"(Reuters) -South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorising the use of Novavax Inc's vaccine on Wednesday and preparing to distribute the first of Pfizer's antiviral pills.At least 21,000 of Pfizer's antiviral pills, called Paxlovid, will arrive in South Korea on Thursday, with another 10,000 more expected to arrive by the end of the month, the health ministry said.The pills, which were authorised for emergency use in December, will begin being used in treatments for more than 1,000 people per day starting on Friday, the ministry added\"By priority, oral treatment is planned to begin first for patients aged 65 or older, or patients with reduced immunity at home and residential treatment centres,\" a ministry spokesperson told a briefing.Paxlovid was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer has said.South Korea's food and drug safety ministry, meanwhile, announced it had authorised the Novavax  vaccine, which joins the ranks of previously authorised vaccines made by AstraZeneca Inc, Moderna Inc, Pfizer, and Johnson & Johnson's Janssen.South Korean vaccine developer SK Bioscience Co Ltd said it will produce the Novavax   vaccine.The two-dose, protein-based vaccine has secured authorisations from European Union regulators and the World Health Organization.It has been authorised in India, Indonesia and the Philippines, where Novavax's partner, Serum Institute of India, will supply it.Novavax is awaiting approval in Japan, where its vaccine would be manufactured and distributed by Takeda Pharmaceutical.At least 84.2% of the country's 52 million population have been fully vaccinated, while 42.5%, have received booster shots, according to health officials.South Korea added 4,388 new COVID-19 cases as of midnight Tuesday, for a total of 674,868 cases and 6,166 deaths since the pandemic began, the Korea Disease Control and Prevention Agency (KDCA) reported.That number has dipped from all-time highs of nearly 8,000 daily cases in mid-December, when authorities re-imposed strict social distancing measures to try to stem the tide.Omicron only accounts for a fraction of South Korea's cases so far, but that percentage has risen to more than 12.5% from 4% at the end of December, health officials said on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002672754,"gmtCreate":1642007332321,"gmtModify":1676533671174,"author":{"id":"4103261011790040","authorId":"4103261011790040","name":"Div Payers","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4103261011790040","authorIdStr":"4103261011790040"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002672754","repostId":"2202784029","repostType":4,"repost":{"id":"2202784029","pubTimestamp":1641975420,"share":"https://ttm.financial/m/news/2202784029?lang=&edition=fundamental","pubTime":"2022-01-12 16:17","market":"us","language":"en","title":"ARK's Wood turns focus to deflation, 'stay connected' stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2202784029","media":"StreetInsider","summary":"NEW YORK (Reuters) -     Star stock picker Cathie Wood of ARK Invest doubled down on her bet that de","content":"<html><head></head><body><p>NEW YORK (Reuters) -     Star stock picker Cathie Wood of ARK Invest doubled down on her bet that deflation, rather than inflation, will be the largest factor in the U.S. economy in the year ahead in a webinar on Tuesday.</p><p>Wood, whose <a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a> was the top-performing U.S. equity fund tracked by Morningstar in 2020 before plummeting to among the worst performers of 2021, pushed back against the idea that companies in her portfolio such as <a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video Communications Inc and Teladoc Health Inc were simply beneficiaries of the economic lockdowns at the start of the coronavirus pandemic.</p><p>&#34;They are not stay-at-home stocks, they are stay connected stocks,&#34; she said.</p><p>Zoom, for instance, should &#34;have stunning growth rates ahead&#34; while Teladoc will become the &#34;backbone&#34; of the U.S. healthcare system, she said.</p><p>Inflation, meanwhile, will fall this year as supply chain bottlenecks ease and companies no longer feel the need to put in double or triple orders for goods, Wood predicted. At the same time, technology will continue to push down prices of goods and services, she said.</p><p>&#34;Companies are learning how powerful technology can be on holding the line on costs,&#34; Wood said.</p><p>The ARK Innovation ETF is down 7.6% for the year to date as rising interest rates have weighed down on the sort of high-growth, high-valuation companIEs in its portfolio.</p><p>The fund was up 3.2% in afternoon trading Monday.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ARK's Wood turns focus to deflation, 'stay connected' stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nARK's Wood turns focus to deflation, 'stay connected' stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-12 16:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19448326><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (Reuters) -     Star stock picker Cathie Wood of ARK Invest doubled down on her bet that deflation, rather than inflation, will be the largest factor in the U.S. economy in the year ahead in ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19448326\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKK":"ARK Innovation ETF","BK4544":"ARK ETF合集"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19448326","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2202784029","content_text":"NEW YORK (Reuters) -     Star stock picker Cathie Wood of ARK Invest doubled down on her bet that deflation, rather than inflation, will be the largest factor in the U.S. economy in the year ahead in a webinar on Tuesday.Wood, whose ARK Innovation ETF was the top-performing U.S. equity fund tracked by Morningstar in 2020 before plummeting to among the worst performers of 2021, pushed back against the idea that companies in her portfolio such as Zoom Video Communications Inc and Teladoc Health Inc were simply beneficiaries of the economic lockdowns at the start of the coronavirus pandemic.\"They are not stay-at-home stocks, they are stay connected stocks,\" she said.Zoom, for instance, should \"have stunning growth rates ahead\" while Teladoc will become the \"backbone\" of the U.S. healthcare system, she said.Inflation, meanwhile, will fall this year as supply chain bottlenecks ease and companies no longer feel the need to put in double or triple orders for goods, Wood predicted. At the same time, technology will continue to push down prices of goods and services, she said.\"Companies are learning how powerful technology can be on holding the line on costs,\" Wood said.The ARK Innovation ETF is down 7.6% for the year to date as rising interest rates have weighed down on the sort of high-growth, high-valuation companIEs in its portfolio.The fund was up 3.2% in afternoon trading Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":182,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002672441,"gmtCreate":1642007313209,"gmtModify":1676533671190,"author":{"id":"4103261011790040","authorId":"4103261011790040","name":"Div Payers","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4103261011790040","authorIdStr":"4103261011790040"},"themes":[],"htmlText":"interesting","listText":"interesting","text":"interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002672441","repostId":"1108839614","repostType":4,"repost":{"id":"1108839614","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641981450,"share":"https://ttm.financial/m/news/1108839614?lang=&edition=fundamental","pubTime":"2022-01-12 17:57","market":"us","language":"en","title":"Bed Bath & Beyond rose nearly 5% premarket as its CFO executed a purchase for 15,000 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1108839614","media":"Tiger Newspress","summary":"Bed Bath & Beyond rose nearly 5% in premarket trading as its CFO executed a purchase for 15,000 shar","content":"<html><head></head><body><p>Bed Bath &amp; Beyond rose nearly 5% in premarket trading as its CFO executed a purchase for 15,000 shares.</p><p><img src=\"https://static.tigerbbs.com/25cca22b92392690393115d9eb15a7ca\" tg-width=\"1018\" tg-height=\"635\" referrerpolicy=\"no-referrer\"/>Gustavo Arnal, Executive Vice President, CFO, on January 07, 2022, executed a purchase for 15,000 shares in Bed Bath &amp; Beyond (BBBY) for $207,150. Following the Form 4 filing with the SEC, Arnal has control over a total of 333,196 shares of the company, with 333,196 shares held directly. The market value of the direct and indirect holding, based on the transaction price, is approximately $4,601,437.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bed Bath & Beyond rose nearly 5% premarket as its CFO executed a purchase for 15,000 shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBed Bath & Beyond rose nearly 5% premarket as its CFO executed a purchase for 15,000 shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-12 17:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Bed Bath &amp; Beyond rose nearly 5% in premarket trading as its CFO executed a purchase for 15,000 shares.</p><p><img src=\"https://static.tigerbbs.com/25cca22b92392690393115d9eb15a7ca\" tg-width=\"1018\" tg-height=\"635\" referrerpolicy=\"no-referrer\"/>Gustavo Arnal, Executive Vice President, CFO, on January 07, 2022, executed a purchase for 15,000 shares in Bed Bath &amp; Beyond (BBBY) for $207,150. Following the Form 4 filing with the SEC, Arnal has control over a total of 333,196 shares of the company, with 333,196 shares held directly. The market value of the direct and indirect holding, based on the transaction price, is approximately $4,601,437.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BBBY":"3B家居"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108839614","content_text":"Bed Bath & Beyond rose nearly 5% in premarket trading as its CFO executed a purchase for 15,000 shares.Gustavo Arnal, Executive Vice President, CFO, on January 07, 2022, executed a purchase for 15,000 shares in Bed Bath & Beyond (BBBY) for $207,150. Following the Form 4 filing with the SEC, Arnal has control over a total of 333,196 shares of the company, with 333,196 shares held directly. The market value of the direct and indirect holding, based on the transaction price, is approximately $4,601,437.","news_type":1},"isVote":1,"tweetType":1,"viewCount":333,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002672566,"gmtCreate":1642007297933,"gmtModify":1676533671190,"author":{"id":"4103261011790040","authorId":"4103261011790040","name":"Div Payers","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4103261011790040","authorIdStr":"4103261011790040"},"themes":[],"htmlText":"amazing","listText":"amazing","text":"amazing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002672566","repostId":"1166686175","repostType":4,"repost":{"id":"1166686175","pubTimestamp":1641983722,"share":"https://ttm.financial/m/news/1166686175?lang=&edition=fundamental","pubTime":"2022-01-12 18:35","market":"us","language":"en","title":"Didi in talks for a second-quarter IPO in Hong Kong on its way to delisting from New York, sources say","url":"https://stock-news.laohu8.com/highlight/detail?id=1166686175","media":"South China Morning Post","summary":"Didi Global is in talks to launch its initial public offering (IPO)in Hong Kong in the second quarte","content":"<html><head></head><body><p>Didi Global is in talks to launch its initial public offering (IPO)in Hong Kong in the second quarter, as China&#39;s dominant ride-hailing company prepares to exit the New York Stock Exchange (NYSE), according to two sources familiar with the matter.</p><p>Didi&#39;s bankers have had preliminary discussions with the Hong Kong Exchanges and Clearing Limited(HKEX) before submitting the A1 form to officially apply to list on the exchange, according to the sources, requesting anonymity for discussing a matter before its announcement.</p><p>Depending on market conditions, the Beijing-based company may list in Hong Kong in the second quarter, the sources said, adding that the financial terms of the proposed listing are still being worked on. HKEX&#39;s spokesman declined to comment on individual cases.</p></body></html>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Didi in talks for a second-quarter IPO in Hong Kong on its way to delisting from New York, sources say</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDidi in talks for a second-quarter IPO in Hong Kong on its way to delisting from New York, sources say\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-12 18:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/didi-talks-second-quarter-ipo-093000904.html><strong>South China Morning Post</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Didi Global is in talks to launch its initial public offering (IPO)in Hong Kong in the second quarter, as China's dominant ride-hailing company prepares to exit the New York Stock Exchange (NYSE), ...</p>\n\n<a href=\"https://finance.yahoo.com/news/didi-talks-second-quarter-ipo-093000904.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIDI":"滴滴(已退市)"},"source_url":"https://finance.yahoo.com/news/didi-talks-second-quarter-ipo-093000904.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166686175","content_text":"Didi Global is in talks to launch its initial public offering (IPO)in Hong Kong in the second quarter, as China's dominant ride-hailing company prepares to exit the New York Stock Exchange (NYSE), according to two sources familiar with the matter.Didi's bankers have had preliminary discussions with the Hong Kong Exchanges and Clearing Limited(HKEX) before submitting the A1 form to officially apply to list on the exchange, according to the sources, requesting anonymity for discussing a matter before its announcement.Depending on market conditions, the Beijing-based company may list in Hong Kong in the second quarter, the sources said, adding that the financial terms of the proposed listing are still being worked on. HKEX's spokesman declined to comment on individual cases.","news_type":1},"isVote":1,"tweetType":1,"viewCount":295,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}